Alzheimer's Research & Therapy, 1758-9193

Journal

More filtering options
  1. 2021
  2. Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology

    L. E.M. Wisse, R. de Flores, L. Xie, S. R. Das, C. T. McMillan, J. Q. Trojanowski, M. Grossman, E. B. Lee, D. Irwin, P. A. Yushkevich, D. A. Wolk & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2021 Dec, In: Alzheimer's Research and Therapy. 13, 100.

    Research output: Contribution to journalArticle

  3. Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging

    Isadora Lopes Alves, Fiona Heeman, Lyduine E. Collij, Gemma Salvadó, Nelleke Tolboom, Natàlia Vilor-Tejedor, Pawel Markiewicz, Maqsood Yaqub, David Cash, Elizabeth C. Mormino, Philip S. Insel, Ronald Boellaard, Bart N.M. van Berckel, Adriaan A. Lammertsma, Frederik Barkhof & Juan Domingo Gispert, 2021 Dec, In: Alzheimer's Research and Therapy. 13, 82.

    Research output: Contribution to journalArticle

  4. Biomarker testing in MCI patients—deciding who to test

    Ingrid S. van Maurik, Hanneke F.M. Rhodius-Meester, Charlotte E. Teunissen, Philip Scheltens, Frederik Barkhof, Sebastian Palmqvist, Oskar Hansson, Wiesje M. van der Flier & Johannes Berkhof, 2021, In: Alzheimer's Research and Therapy. 13, 1, 14.

    Research output: Contribution to journalArticle

  5. Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

    Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte E. Teunissen & Kaj Blennow, 2021, In: Alzheimer's Research and Therapy. 13, 1, 38.

    Research output: Contribution to journalArticle

  6. In vivo tau pathology is associated with synaptic loss and altered synaptic function

    Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel, Sander C.J. Verfaillie, Emma E. Wolters, Ronald Boellaard, Rik Ossenkoppele, Anouk den Braber, Wiep Scheper, Patrick Schober, Steven P. Sweeney, J. Michael Ryan, Robert C. Schuit, Albert D. Windhorst, Frederik Barkhof, Philip Scheltens, Sandeep S.V. Golla, Arjan Hillebrand, Alida A. Gouw & Bart N.M. van Berckel, 2021, In: Alzheimer's Research and Therapy. 13, 1, 35.

    Research output: Contribution to journalArticle

  7. 2020
  8. Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

    Inge M.W. Verberk, Elisabeth Thijssen, Jannet Koelewijn, Kimberley Mauroo, Jeroen Vanbrabant, Arno De Wilde, Marissa D. Zwan, Sander C.J. Verfaillie, Rik Ossenkoppele, Frederik Barkhof, Bart N.M. Van Berckel, Philip Scheltens, Wiesje M. Van Der Flier, Erik Stoops, Hugo M. Vanderstichele & Charlotte E. Teunissen, 2020 Sep 28, In: Alzheimer's Research and Therapy. 12, 1, 118.

    Research output: Contribution to journalArticle

  9. Relevance of biomarkers across different neurodegenerative

    Alexander J. Ehrenberg, Ayesha Khatun, Emma Coomans, Matthew J. Betts, Federica Capraro, Elisabeth H. Thijssen, Konstantin Senkevich, Tehmina Bharucha, Mehrsa Jafarpour, Peter N.E. Young, William Jagust, Stephen F. Carter, Tammaryn Lashley, Lea T. Grinberg, Joana B. Pereira, Niklas Mattsson-Carlgren, Nicholas J. Ashton, Jörg Hanrieder, Henrik Zetterberg, Michael Schöll & 1 others, Ross W. Paterson, 2020 May 13, In: Alzheimer's Research and Therapy. 12, 56.

    Research output: Contribution to journalReview article

  10. Imaging biomarkers in neurodegeneration: Current and future practices

    Peter N.E. Young, Mar Estarellas, Emma Coomans, Meera Srikrishna, Helen Beaumont, Anne Maass, Ashwin V. Venkataraman, Rikki Lissaman, Daniel Jiménez, Matthew J. Betts, Eimear McGlinchey, David Berron, Antoinette O'Connor, Nick C. Fox, Joana B. Pereira, William Jagust, Stephen F. Carter, Ross W. Paterson & Michael Schöll, 2020 Apr 27, In: Alzheimer's Research and Therapy. 12, 1, 49.

    Research output: Contribution to journalReview article

  11. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg

    Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andreasson, Erik Portelius, Nicholas J. Ashton, Kaj Blennow, Michael Schöll, Ross W. Paterson, Jonathan M. Schott & Henrik Zetterberg, 2020 Feb 28, In: Alzheimer's Research and Therapy. 12, 1, 20.

    Research output: Contribution to journalReview article

  12. Alpha-amylase 1A copy number variants and the association with memory performance and Alzheimer’s dementia

    Elin Byman, Katarina Nägga, Anna Märta Gustavsson, Johanna Andersson-Assarsson, Oskar Hansson, Emily Sonestedt, Malin Wennström & The Netherlands Brain Bank The Netherlands Brain Bank, 2020, In: Alzheimer's Research and Therapy. 12, 1, 158.

    Research output: Contribution to journalArticle

  13. Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease

    Ellen H. Singleton, Yolande A.L. Pijnenburg, Carole H. Sudre, Colin Groot, Elena Kochova, Frederik Barkhof, Renaud La Joie, Howard J. Rosen, William W. Seeley, Bruce Miller, M. Jorge Cardoso, Janne Papma, Philip Scheltens, Gil D. Rabinovici & Rik Ossenkoppele, 2020, In: Alzheimer's Research and Therapy. 12, 1, 148.

    Research output: Contribution to journalArticle

  14. Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

    K. Minta, G. Brinkmalm, S. Janelidze, S. Sjödin, E. Portelius, E. Stomrud, H. Zetterberg, K. Blennow, O. Hansson & U. Andreasson, 2020, In: Alzheimer's Research and Therapy. 12, 1, 19.

    Research output: Contribution to journalArticle

  15. 2019
  16. High occurrence of transportation and logistics occupations among vascular dementia patients: An observational study

    A. C. Van Loenhoud, C. De Boer, K. Wols, Y. A. Pijnenburg, A. W. Lemstra, F. H. Bouwman, N. D. Prins, P. Scheltens, R. Ossenkoppele & W. M. Van Der Flier, 2019 Dec 27, In: Alzheimer's Research and Therapy. 11, 1, 112.

    Research output: Contribution to journalArticle

  17. Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume

    Jessica Z.K. Caldwell, Jeffrey L. Cummings, Sarah J. Banks, Sebastian Palmqvist & Oskar Hansson, 2019 Dec 26, In: Alzheimer's Research & Therapy. 11, 1, 109.

    Research output: Contribution to journalArticle

  18. Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

    Simon Sjödin, Gunnar Brinkmalm, Annika Öhrfelt, Lucilla Parnetti, Silvia Paciotti, Oskar Hansson, John Hardy, Kaj Blennow, Henrik Zetterberg & Ann Brinkmalm, 2019 Sep 14, In: Alzheimer's Research and Therapy. 11, 1, 82.

    Research output: Contribution to journalArticle

  19. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

    Arno De Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. Van Der Flier, Philip Scheltens, Bart N.M. Van Berckel, Femke Bouwman & Rik Ossenkoppele, 2019 Sep 12, In: Alzheimer's Research and Therapy. 11, 78.

    Research output: Contribution to journalArticle

  20. Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum

    Tessa Timmers, Rik Ossenkoppele, Emma E. Wolters, Sander C.J. Verfaillie, Denise Visser, Sandeep S.V. Golla, Frederik Barkhof, Philip Scheltens, Ronald Boellaard, Wiesje M. Van Der Flier & Bart N.M. Van Berckel, 2019 Jul 4, In: Alzheimer's Research and Therapy. 11, 1, 60.

    Research output: Contribution to journalArticle

  21. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

    Oskar Hansson, Sylvain Lehmann, Markus Otto, Henrik Zetterberg & Piotr Lewczuk, 2019 Apr 22, In: Alzheimer's Research and Therapy. 11, 1, p. 1-15 15 p.

    Research output: Contribution to journalReview article

  22. Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: Protocol of the BEAT-IT study

    Willem S. Eikelboom, Ellen Singleton, Esther Van Den Berg, Michiel Coesmans, Francesco Mattace Raso, Rozemarijn L. Van Bruchem, Jeannette A. Goudzwaard, Frank Jan De Jong, Marc Koopmanschap, Tom Den Heijer, Jan J.M. Driesen, Lilian J.H.M. Vroegindeweij, Elsbeth C. Thomeer, Susanne E. Hoogers, Anke A. Dijkstra, Sytse U. Zuidema, Yolande A.L. Pijnenburg, Philip Scheltens, John C. Van Swieten, Rik Ossenkoppele & 1 others, Janne M. Papma, 2019, In: Alzheimer's Research and Therapy. 11, 1, 48.

    Research output: Contribution to journalArticle

  23. 2018
  24. Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele

    Anna Catharina Van Loenhoud, Colin Groot, Jacob William Vogel, Wiesje Maria Van Der Flier & Rik Ossenkoppele, 2018 Sep 11, In: Alzheimer's Research and Therapy. 10, 1, 91.

    Research output: Contribution to journalReview article

  25. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: A 22-year follow-up study

    Steinunn Thordardottir, Elena Rodriguez-Vieitez, Ove Almkvist, Daniel Ferreira, Laure Saint-Aubert, Anne Kinhult-Ståhlbom, Håkan Thonberg, Michael Schöll, Eric Westman, Anders Wall, Maria Eriksdotter, Henrik Zetterberg, Kaj Blennow, Agneta Nordberg & Caroline Graff, 2018 May 10, In: Alzheimer's Research and Therapy. 10, 1, 45.

    Research output: Contribution to journalArticle

  26. Slowly progressive dementia caused by MAPT R406W mutations: Longitudinal report on a new kindred and systematic review

    Emil Ygland, Danielle Van Westen, Elisabet Englund, Rosa Rademakers, Zbigniew K. Wszolek, Karin Nilsson, Christer Nilsson, Maria Landqvist Waldö, Irina Alafuzoff, Oskar Hansson, Lars Gustafson & Andreas Puschmann, 2018 Jan 9, In: Alzheimer's Research and Therapy. 10, 1, 2.

    Research output: Contribution to journalArticle

  27. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

    Kalicharan Patra, Antoninus Soosaipillai, Sigrid Botne Sando, Camilla Lauridsen, Guro Berge, Ina Møller, Gøril Rolfseng Grøntvedt, Geir Bråthen, Ilijana Begcevic, Simon Moussaud, Lennart Minthon, Oskar Hansson, Eleftherios P. Diamandis, Linda R. White & Henrietta M. Nielsen, 2018, In: Alzheimer's Research and Therapy. 10, 1, 9.

    Research output: Contribution to journalArticle

  28. 2017
  29. Cerebrovascular and amyloid pathology in predementia stages: The relationship with neurodegeneration and cognitive decline

    Isabelle Bos, Frans R. Verhey, Inez H.G.B. Ramakers, Heidi I.L. Jacobs, Hilkka Soininen, Yvonne Freund-Levi, Harald Hampel, Magda Tsolaki, Åsa K. Wallin, Mark A. Van Buchem, Ania Oleksik, Marcel M. Verbeek, Marcel Olde Rikkert, Wiesje M. Van Der Flier, Philip Scheltens, Pauline Aalten, Pieter Jelle Visser & Stephanie J.B. Vos, 2017 Dec 29, In: Alzheimer's Research and Therapy. 9, 1, 101.

    Research output: Contribution to journalArticle

  30. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Ronald Lautner, Philip S. Insel, Tobias Skillbäck, Bob Olsson, Mikael Landén, Giovanni B Frisoni, Sanna-Kaisa Herukka, Harald Hampel, Anders Wallin, Lennart Minthon, Oskar Hansson, Kaj Blennow, Niklas Mattsson & Henrik Zetterberg, 2017 Oct 23, In: Alzheimer's Research and Therapy. 9, 1, 87.

    Research output: Contribution to journalArticle

  31. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

    Hugo Vanderstichele, Leentje Demeyer, Shorena Janelidze, Els Coart, Erik Stoops, Kimberley Mauroo, Victor Herbst, Cindy François & Oskar Hansson, 2017 Jun 6, In: Alzheimer's Research and Therapy. 9, 1, 40.

    Research output: Contribution to journalArticle

  32. 2016
  33. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

    Annika Öhrfelt, Ann Brinkmalm, Julien Dumurgier, Gunnar Brinkmalm, Oskar Hansson, Henrik Zetterberg, Elodie Bouaziz-Amar, Jacques Hugon, Claire Paquet & Kaj Blennow, 2016 Oct 3, In: Alzheimer's Research & Therapy. 8, 1, 10 p.

    Research output: Contribution to journalArticle

  34. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

    Kristi Henjum, Ina S. Almdahl, Vibeke Årskog, Lennart Minthon, Oskar Hansson, Tormod Fladby & Lars N G Nilsson, 2016, In: Alzheimer's Research & Therapy. 8, 1, 182.

    Research output: Contribution to journalArticle

  35. 2015
  36. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

    Hlin Kvartsberg, Erik Portelius, Ulf Andreasson, Gunnar Brinkmalm, Konstantin Hellwig, Natalia Lelental, Johannes Kornhuber, Oskar Hansson, Lennart Minthon, Philipp Spitzer, Juan M. Maler, Henrik Zetterberg, Kaj Blennow & Piotr Lewczuk, 2015, In: Alzheimer's Research & Therapy. 7, 1, 40.

    Research output: Contribution to journalArticle

  37. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

    Katrin Jekel, Marinella Damian, Carina Wattmo, Lucrezia Hausner, Roger Bullock, Peter J Connelly, Bruno Dubois, Maria Eriksdotter, Michael Ewers, Elmar Graessel, Milica G Kramberger, Emma Law, Patrizia Mecocci, José L Molinuevo, Louise Nygård, Marcel Gm Olde-Rikkert, Jean-Marc Orgogozo, Florence Pasquier, Karine Peres, Eric Salmon & 6 others, Sietske Am Sikkes, Tomasz Sobow, René Spiegel, Magda Tsolaki, Bengt Winblad & Lutz Frölich, 2015, In: Alzheimer's Research & Therapy. 7, 1, 17.

    Research output: Contribution to journalReview article

  38. 2014
  39. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

    Oskar Hansson, Sara Hall, Annika Ohrfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Katarina Nägga, Elisabet Londos, Shiji Varghese, Nour K Majbour, Abdulmonem Al-Hayani & Omar Ma El-Agnaf, 2014, In: Alzheimer's Research & Therapy. 6, 3, 25.

    Research output: Contribution to journalArticle

  40. 2013
  41. Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

    Carina Wattmo, Erik Jedenius, Kaj Blennow & Åsa Wallin, 2013, In: Alzheimer's Research & Therapy. 5, 1, 2.

    Research output: Contribution to journalArticle

  42. Plasma tau levels in Alzheimer's disease

    Henrik Zetterberg, David Wilson, Ulf Andreasson, Lennart Minthon, Kaj Blennow, Jeffrey Randall & Oskar Hansson, 2013, In: Alzheimer's Research & Therapy. 5, 2, 9.

    Research output: Contribution to journalLetter

  43. 2010